← Back to Clinical Trials
Recruiting NCT06368713

Exercise Improves Gastrointestinal Function in Peritoneal Dialysis Patients

◆ AI Clinical Summary

This study looks at whether regular exercise can help improve digestion and stomach function in people who use peritoneal dialysis for kidney disease treatment. Researchers will examine how physical activity affects gastrointestinal symptoms and function in these patients.

Key Objective: The trial is testing whether exercise can improve digestive function and reduce gastrointestinal problems in peritoneal dialysis patients.

Who to Consider: Peritoneal dialysis patients experiencing gastrointestinal issues or those interested in understanding how exercise might improve their digestive health should consider participating.

Trial Parameters

Condition Peritoneal Dialysis
Sponsor Sichuan Academy of Medical Sciences
Study Type INTERVENTIONAL
Phase N/A
Enrollment 132
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2024-03-01
Completion 2025-06-30
Interventions
Exercise

Brief Summary

This study will investigate the impact of exercise on gastrointestinal function in peritoneal dialysis patients.

Eligibility Criteria

Inclusion Criteria: 1. Patients must have undergone peritoneal dialysis for more than 3 months. 2. Age between 18 and 65 years. 3. Possession of a smartphone and proficiency in its usage. 4. Willingness to provide voluntary informed consent by signing the consent form. Exclusion Criteria: 1. Recent systolic blood pressure ≥180 mmHg or diastolic blood pressure ≥110 mmHg, or systolic blood pressure ≤90 mmHg or diastolic blood pressure ≤60 mmHg within the past week. 2. Presence of severe cardiovascular diseases, including but not limited to: * Heart failure classified as New York Heart Association (NYHA) functional grade IV-V. * Severe arrhythmias such as third-degree atrioventricular block, sick sinus syndrome, paroxysmal supraventricular tachycardia, or ventricular tachycardia. * Unstable angina. * Pulmonary arterial hypertension with pulmonary arterial pressure ≥25 mmHg. * Severe pericardial effusion, valve stenosis, hypertrophic cardiomyopathy, or aortic dissection. 3. Severe pulmonar

Related Trials